ArticleEuroasian journal of hepato-gastroenterology
Improvement in Health-related Quality of Life and Patient Satisfaction after Pneumatic Dilatation in Achalasia Patients.
Article in Euroasian journal of hepato-gastroenterology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Achalasia, a rare motility disorder characterized by impaired lower esophageal sphincter relaxation, significantly impacts patients' quality of life. Pneumatic dilatation (PD) is a cost-effective and minimally invasive treatment, yet long-term prospective data from resource-limited settings remain scarce. This study aimed to evaluate the efficacy of PD in improving health-related quality of life (HRQoL) and patient satisfaction among achalasia patients in a peripheral Pakistani hospital. Materials and methods: A single-center, quasi-experimental study was conducted at Madina Teaching Hospital, Faisalabad, from 2017 to 2021. Eighty patients (mean age: 37.03 ± 10.49 years) diagnosed via high-resolution manometry or barium swallow were enrolled. Pneumatic dilatation was performed under fluoroscopic and endoscopic guidance using 35 and 40 mm balloons. Outcomes were assessed at baseline, 6 months, and 24 months using the Eckardt score and Short Form-8 Health Survey Questionnaire. Statistical analyses included repeated measures analysis of variance, Kaplan-Meier survival analysis, and Spearman's correlation. Results: Pneumatic dilatation resulted in a 75.1% reduction in Eckardt scores at 24 months ( Conclusion: Pneumatic dilatation is a safe, effective, and sustainable intervention for achalasia in resource-limited settings. It provides durable symptom relief, significantly improves HRQoL, and achieves high patient satisfaction over 24 months, with minimal complications. These findings highlight PD's viability as a first-line treatment in regions with limited access to advanced therapeutic options. How to cite this article: Hanif S, Rasool S, Shafqat U,
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.